- Home
- / Solasia Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Solasia Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
¥429 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| JPY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 318.0M | 1.3B | 454.0M | 559.0M | 1.1B | 617.0M | 316.0M | 429.0M |
| Cost of goods sold | 60.0M | (410.0M) | (287.0M) | (310.0M) | (104.0M) | (220.0M) | (64.0M) | 184.0M |
| Gross profit | 258.0M | 1.7B | 741.0M | 869.0M | 1.2B | 837.0M | 380.0M | 245.0M |
| Gross profit margin, % | 131.3% | 163.2% | 155.5% | 109.5% | 135.7% | 120.3% | 57.1% | |
| Operating expense total | 2.5B | 3.0B | 4.4B | 2.8B | 3.1B | 1.5B | 2.1B | 1.1B |
| Depreciation and amortization | 153.0M | 475.0M | 496.0M | 495.0M | 534.0M | 500.0M | 195.0M | 37.0M |
| EBITDA | (2.3B) | (1.3B) | (3.6B) | (1.9B) | (1.9B) | (639.0M) | (1.8B) | (823.0M) |
| EBITDA margin, % | -98.2% | -797.1% | -344.2% | -177.7% | -103.6% | -556.6% | -191.8% | |
| EBIT | (2.4B) | (1.8B) | (4.1B) | (2.4B) | (2.5B) | (1.1B) | (2.0B) | (860.0M) |
| EBIT margin, % | -134.5% | -906.6% | -432.7% | -226.6% | -184.6% | -618.4% | -200.5% | |
| Interest income | 10.0M | 1.0M | ||||||
| Interest expense | 35.0M | 43.0M | 23.0M | 18.0M | 6.0M | 14.0M | ||
| Pre tax profit | (2.4B) | (1.8B) | (4.2B) | (2.4B) | (2.5B) | (1.1B) | (2.0B) | (876.0M) |
| Income tax expense | (23.0M) | 70.0M | (32.0M) | 36.0M | 56.0M | (23.0M) | (20.0M) | |
| Net Income | (2.4B) | (1.9B) | (4.1B) | (2.5B) | (2.5B) | (1.1B) | (1.9B) | (876.0M) |